MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK

被引：0
|
作者：
Brennan, A. [1 ]
Bansback, N. [1 ]
Conway, P. [2 ]
Reynolds, A. [2 ]
机构：
[1] Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[2] Wyeth Labs, Maidenhead, Berks, England
来源：
RHEUMATOLOGY | 2002年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK
    Brennan, A
    Bansback, N
    Reynolds, A
    Conway, P
    [J]. RHEUMATOLOGY, 2004, 43 (01) : 62 - 72
  • [2] Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis (RA) in the UK.
    Brennan, A
    Bansback, N
    Conway, P
    Reynolds, AV
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S157 - S157
  • [3] A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK.
    Bansback, N
    Brennan, A
    Conway, P
    Reynolds, AV
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S582 - S582
  • [4] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN CHINA
    Zhang, Y.
    Yang, L.
    Dong, P.
    Xie, X.
    Tang, B.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A673 - A673
  • [5] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN PORTUGAL
    Mateus, C.
    Moura, A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A380 - A381
  • [6] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO
    Vargas-Valencia, J.
    Sotelo-Guzman, M.
    Mould-Quevedo, J. F.
    Mucino-Ortega, E.
    Galindo-Suarez, R. M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [7] A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Chen, Y-F
    Jobanputra, P.
    Barton, P.
    Jowett, S.
    Bryan, S.
    Clark, W.
    Fry-Smith, A.
    Burls, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) : 1 - +
  • [8] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Alex Diamantopoulos
    A. Finckh
    T. Huizinga
    D. K. Sungher
    L. Sawyer
    D. Neto
    F. Dejonckheere
    [J]. PharmacoEconomics, 2014, 32 : 775 - 787
  • [9] COST-EFFECTIVENESS OF BIOLOGIC THERAPEUTIC SEQUENCES FOR RHEUMATOID ARTHRITIS IN THE UK
    Emery, P.
    Taylor, P.
    Isaacs, J. D.
    Drost, P.
    Dupont, D.
    Beresniak, A.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A439 - A439
  • [10] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Diamantopoulos, Alex
    Finckh, A.
    Huizinga, T.
    Sungher, D. K.
    Sawyer, L.
    Neto, D.
    Dejonckheere, F.
    [J]. PHARMACOECONOMICS, 2014, 32 (08) : 775 - 787
12345